Journal profile · Multiple
Infectious Microbes & Diseases
ISSN 2641-5917 · Wolters Kluwer Health · United States
Infectious Microbes & Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.1 (journal website); fully open access; APC about USD 1,800; median 77 days to acceptance (18 articles, last 24 months); 30 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Infectious Microbes & Diseases is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gut microbiota and health, COVID-19 Clinical Research Studies and Antibiotic Resistance in Bacteria, together about 23.1% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Infectious Microbes & Diseases (IMD) is an international open-access peer-reviewed journal that is dedicated to accelerate the dissemination, exchange and utilization of basic, applied and clinical scientific research results related to the field of infectious microbes and infectious diseases.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Yonghong XiaoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology8.4%
- COVID-19 Clinical Research StudiesMedicine7.6%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology7.2%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.8%
- Liver Disease Diagnosis and TreatmentMedicine6%
- Clostridium difficile and Clostridium perfringens researchMedicine5.6%
- HIV/AIDS Research and InterventionsMedicine4.8%
- HIV Research and TreatmentImmunology and Microbiology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: no
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.32LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 36OpenAlex ·
- 2-year mean citedness
- 1.54OpenAlex ·
- Self-citation rate
- 23.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 22LetPub ·
Articles by year OpenAlex count · 220 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 0 |
| 2025 | 30 | 30 | 43 |
| 2024 | 32 | 32 | 85 |
| 2023 | 26 | 26 | 132 |
| 2022 | 32 | 32 | 133 |
| 2021 | 32 | 32 | 223 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
77 daysMedian, submission to acceptance · P25–P75 53 days – 100 days
- Acceptance to online
- median 20 days (18 articles)
- Submission to online
- median 107 days
- Sample
- 18 articles with submission and acceptance dates (61 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,800 | Yes | CC BY, CC BY-SA, CC BY-ND, CC BY-NC, CC BY-NC-SA, CC BY-NC-ND | |
| OpenAlex | USD 1,800 | — | — | |
| LetPub | USD 1,800 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7, with length limits
- case reportCase Report 1500 150, unstructured abstract 2 15 NoLength not stated
- commentComment 1000 No abstract 1 10 NoLength not stated
- editorialEditorial 2000 No abstract 2 30 NoLength not stated
- guideline articleGuideline Article 4000 250, unstructured abstract 6 50 YesLength not stated
- letterround and the rationale for the letter. Letters can only have 2000 words and 4 tables/figures. Case Reports are short articles repormain text ≤ 2,000 words
- original articleOriginal Article 4000 250, unstructured abstract 6 50 YesLength not stated
- review articlehave an abstract of maximum 250 words and a word count of approximatelymain text ≤ 250 words · abstract ≤ 250 words
Policy excerpts from the journal's websiteConflicts of interest, Data availability, Plagiarism
- Conflicts of interest Disclosure of Conflicts
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources …
Source ↗Publisher website ·- Data availability Data Availability Statement
Retraction Policy: IMD should consider retracting a publication if: Model summary
Infectious Microbes & Diseases requires authors to include in any articles that report results derived from research data to include a Data Availability Statement from Apr 2023. The provision of a Data Availability Statement will be verified as a condition of publication. Data Availability Statements should include information on where data supporting the results reported in the article can be fou…
Source ↗Publisher website ·- Plagiarism Plagiarism
As defined by the World Association of Medical Editors (https://www.wame.org/resources):
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- United States
- Language
- English
- ISSN
- 2641-5917
- Print ISSN
- 2096-7241
- Latest issue on the website
- Volume 8, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Infectious Microbes & Diseases
What CAS zone is Infectious Microbes & Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Infectious Microbes & Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Microbiology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Infectious Microbes & Diseases?
The journal's website gives an impact factor of 2.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.1, h-index 18.
How long does peer review take at Infectious Microbes & Diseases?
Based on the dates recorded on 18 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 77 days (interquartile range 53–100 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Infectious Microbes & Diseases?
According to LetPub and DOAJ records, Infectious Microbes & Diseases is indexed in ESCI, Scopus and DOAJ.
Is Infectious Microbes & Diseases open access, and what is the APC?
Infectious Microbes & Diseases is a fully open-access journal. APC about USD 1,800.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .